Christopher Winter - Concepedia

Author

Christopher Winter

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

C Winter, C. Winter, Christopher G Winter, Christopher G. Winter, Christopher Winter, Winter, Christopher

130

Publications

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Sanofi (United States)University of Alberta United States Military Academy Dana-Farber Cancer Institute

About

Christopher Winter is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	3.3K
2	Natural Sciences	3	3	170
3	Biochemistry	3	3	314
4	Engineering	2	2	62
5	Health Sciences	1	1	13

Christopher Winter

Publications

Citations

H-Index

Page 1

	Year	Citations
Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome Annette L. Parks, Kevin R Cook, Marcia Belvin, Nature Genetics BiologyDrosophila Melanogaster GenomeGeneticsGenome StructureSystematic Generation	2004	770
<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors Jennifer O’Neil, Jonathan Grim, Peter R. Strack, The Journal of Experimental Medicine	2007	657
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay S. Sethi, Xudong Dai, Christopher Winter, Cancer Cell Breast OncologyBone Morphogenic ProteinMedicineBone CellsBreast Cancer	2011	567
Drosophila Rho-Associated Kinase (Drok) Links Frizzled-Mediated Planar Cell Polarity Signaling to the Actin Cytoskeleton Christopher Winter, Bruce Wang, Anna C. Ballew, Cell Developmental BiologySignal TransductionSignaling PathwayMedicineCell Interaction	2001	545
An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies Jennifer O’Neil, Yair Benita, Igor Feldman, Molecular Cancer Therapeutics Drug TargetCombination Drug TherapyTumor BiologyOncologyCancer Cell Biology	2016	410
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway Margit Hagel, Chandra Miduturu, Michael P. Sheets, Cancer Discovery	2015	305
Essential Roles of Drosophila RhoA in the Regulation of Neuroblast Proliferation and Dendritic but Not Axonal Morphogenesis Tzumin Lee, Christopher Winter, Simone Marticke, Neuron Axonal MorphogenesisDevelopmental BiologyDevelopmental GeneticsDrosophila RhoaMorphogenesis	2000	287
Regulating Axon Branch Stability Pierre Billuart, Christopher Winter, Alison Maresh, Cell Molecular PhysiologyDevelopmental BiologyCytoskeletonFunctional RegulationAxon Branch Stability	2001	208
Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells Sudhir Rao, Jennifer O’Neil, Cole D. Liberator, Cancer Research	2009	164
Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition Michael Lampa, Heike Arlt, Timothy He, PLoS ONE Breast OncologyTumor CellsMetabolic RemodelingCancer BiologyTumor Biology	2017	156

Page 1